A reverse transcriptase-polymerase chain reaction procedure (RT-PCR) f
or the detection of hepatitis G virus (HGV) RNA was used to examine th
e prevalence of HGV infection and HGV-related disease in Japan. Among
48 patients with acute non-A, B, C, D, E (non-A-E) hepatitis (five tra
nsfusion-associated cases and 43 sporadic cases), only one patient (2%
), a transfusion recipient, was HGV RNA positive. Similarly, among 50
patients with established chronic non-A-E hepatitis, only two (4%) wer
e positive for HGV RNA. These frequencies were not significantly diffe
rent from those in 129 voluntary blood donors (0.8%). By contrast, HGV
infection was relatively common among patients who were also infected
with other hepatitis viruses. HGV co-infection or superinfection was
found in seven of 53 (13%) patients with acute hepatitis C, in 15 of 1
26 (12%) patients with chronic hepatitis C, in three of 21 (14%) patie
nts with acute hepatitis B and in four of 81 (5%) patients with chroni
c hepatitis B. Among the 29 dually infected patients, 15 (52%) had a h
istory of blood transfusion. HGV was also detected in seven (10%) of 6
9 haemodialysis patients, of whom only one had a dual infection with h
epatitis C virus (HCV) and an elevated aminotransferase level. In conc
lusion: HGV RNA was found in only a low percentage of patients with ei
ther acute or chronic non-A-E hepatitis; HGV appears toco-infect or su
perinfect in 10-15% of HCV infections and in 5-15% of HBV infections;
the prevalence of HGV infection (0.8%) among voluntary blood donors in
Japan is similar to that for HCV infection; a history of blood transf
usion was obtained in 22 (55%) of the total 40 HGV-positive subjects;
and isolated HGV infection appears to have a low disease burden.